| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.04 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |